Brain-Derived Neurotrophic Factor and Neuropsychiatric Disorders

By Anita E. Autry, L. Monteggia. Pharmacological Reviews, 2012

1,357 citations recorded by the source corpus.

Subfields: Cellular and Molecular Neuroscience, Cognitive Neuroscience

View Paper: https://www.semanticscholar.org/paper/b6e92948212a5490e49ac9288cffda9f90a83e38

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cellular and Molecular Neuroscience

1. C. Björkholm
2. L. Monteggia
3. M. Chao
4. P. Bekinschtein
5. E. Nestler

In Cognitive Neuroscience

1. L. Monteggia
2. P. Bekinschtein

Citations in the corpus

• Exercise promotes the expression of brain derived neurotrophic factor (BDNF) through the action of the ketone body β-hydroxybutyrate (2016, background): “…question, since cognitive ability and synaptic plasticity are influenced by the levels of BDNF (Lu et al., 2013; Park and Poo, 2013; Vaynman et al., 2004) and BDNF signaling is reduced in many neurodegenerative and psychi- atric diseases (Autry and Monteggia, 2012; Zuccato and Cattaneo, 2009).”
• GDNF, NGF and BDNF as therapeutic options for neurodegeneration. (2013, background): “This review deals mainly with neurodegeneration, with a mention of Rett syndrome, other reviews deal in more detail in particular with BDNF and neuropsychiatric disorders (Autry & Monteggia, 2012; Balaratnasingam & Janca, 2012).”
• Brain-Derived Neurotrophic Factor: A Key Molecule for Memory in the Healthy and the Pathological Brain (2019, background): “In the last few years, evidence from animal models and clinical studies strongly suggest that dysregulation of neurotrophic factors could play an important role in the etiology of the bipolar disorder (BD), major depressive disorder (MDD), and schizophrenia (SZ) (Duman and Monteggia, 2006; Autry and”
• BDNF — a key transducer of antidepressant effects (2015, background): “BDNF has also been implicated in a number of psychiatric disorders, including schizophrenia, intellectual disability and autism, and the development of mood disorders such as depression and its treatment (Autry and Monteggia, 2012).”